- Blood Pressure and Brain Blood Flow Regulation After Midodrine Administration in Those With Spinal Cord Injury
- Lower Body Muscle Pre-activation in Initial Orthostatic Hypotension
- Orthostatic Intolerance After Bariatric Surgery
- Orthostatic Intolerance and Hypotension After Administration of Morphine in Patients Prior to Hip Arthroplasty
- Pathophysiologic Hemodynamics After Primary Unilateral Total Hip Arthroplasty (THA)
- Pathophysiologic Hemodynamics After Primary Unilateral Total Hip Arthroplasty in Patients Receiving ACEIs and ARBs
- Postoperative Incidence of Orthostatic Intolerance and Hypotension in Primary Unicompartmental Knee Arthroplasty (UKA)
- Postoperative Orthostatic Intolerance and Hypotension in Unilateral TKA
- Sex Hormones and Orthostatic Tolerance
- The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
- The Pathophysiology of Orthostatic Hypotension
- Treatment of Orthostatic Hypotension
- Treatment of Orthostatic Intolerance in Patients With Parkinson’s Disease Using Midodrine
Clinical Trials
- A Clinical Trial Testing the Efficacy of PDT in Preventing Amputation in Diabetic Patients
- Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization
- Acute Non-severe Osteomyelitis in Children – Outpatient Management Strategy With Oral Antibiotic Therapy Compared to a Standard Strategy With Conventional Hospitalization and Intravenous Antibiotic Therapy: a Randomized Open-label Non-inferiority Study With Bayesian and Medical-economic Analyses.
- Acute Posttraumatic Osteomyelitis in Patients With High-energy Tibial Fractures and Biomarkers
- Additional Hyperbaric Oxygen After Lower Extremity Amputation
- Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use
- Assessment of PCR Multiplex Tests as a Tool to Obtain a Quicker Diagnosis of Bacteria Responsible for Foot Osteomyelitis Than Usual Cultures
- Bacteriophage Therapy in Patients With Diabetic Foot Osteomyelitis
- Ceftaroline for Treatment of Hematogenously Acquired Staphylococcus Aureus Osteomyelitis in Children
- Ceftaroline in the Treatment of Bone and Joint Infections
- Ceftriaxone as Home IV for Staph Infections
- CERAMENT™|G – Bone Healing and Re-infection Prophylaxis
- Clinical Effectiveness of S53P4 Bioactive Glass in Treatment of Long-bone Chronic Osteomyelitis
- Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
- Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis
- Denosumab Related Osteonecrossi of the Jaw : : an Emergent and Potentially Complex Bone and Joint Infection
- Detection of Osteomyelitis Using High Resolution Ultrasound
- Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized Patients
- Diagnostic Tests to Help Determine Osteomyelitis
- Drug Delivery Devices for Osteomyelitis
- Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
- Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers
- Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones
- Fosfomycin i.v. for Treatment of Severely Infected Patients
- Gentamicin-loaded Calciumsulfate-hydroxyapatite Biocomposite to Treat Diabetic Foot Ulcers With Infections
- Intramedullary Calcium Sulfate Antibiotic Depot
- Investigation of Rifampin to Reduce Pedal Amputations for Osteomyelitis in Diabetics
- Investigation of the Use of Hyperspectral Imaging in Foot Surgery Patients
- Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care
- Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis
- Osteomyelitis: Procalcitonin to Diagnose and Monitor Osteomyelitis (PCT)
- Patients Response to Early Switch To Oral:Osteomyelitis Study
- PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
- Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections
- Procalcitonin Level and Kinetics in Children With Bacterial Infections
- Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial
- RETR(Osteomyelitis)
- Risk Factors for Three Critical Stages of the Diabetic Foot Infections
- Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Patients With Osteomyelitis
- Short or Long Antibiotic Regimes in Orthopaedics
- Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis.
- Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci
- Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis
- The Influence of Bisphosphonates in the Oral Cavity in Children
- The RAD-HOME Project: a Pilot Study of Domiciliary Teleradiology
- Treatment of Fracture Related Infection in Latin America.
- Treatment of Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and Anti-bacterial Agents
- UT Southwestern Diabetic Foot Ulcers (DFU) and Osteomyelitis (DFO) Recruitment Database, Data and Tissue Repository
- Vancomycin Or Trimethoprim/Sulfamethoxazole for Methicillin-resistant Staphylococcus Aureus (MRSA) Osteomyelitis (VOTSMO)
- 28mm Ceramic-on-Ceramic Total Hip Replacement Study
- A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty
- A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement
- A Clinical Investigation of the Balance® Microplasty™ Hip System
- A Clinical Investigation of the C2a-Taper™ Acetabular System
- A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems
- A Clinical Investigation of the Copeland™ Humeral Resurfacing Head
- A Clinical Investigation of the Discovery™ Elbow System
- A Clinical Investigation of the M2a- 38™ Hip System
- A Clinical Investigation of the M2a- Taper™ Hip System
- A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System
- A Clinical Investigation of the Taperloc® Microplasty™ Hip System
- A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China
- A Comparison of Impingement Free Range of Motion With CT Scan After Manual and Robotic Total Hip Replacement
- A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing
- A Comparison of Two Different Surgical Techniques in Hip Resurfacing Arthroplasty
- A Multi-centre Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement
- A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup
- A Novel Reconstruction Device for Osteonecrotic Femoral Head Efficacy Evaluation
- A Prospective Clinical Study On A Total Hip Resurfacing System
- A Prospective Clinical Study On A Total Hip Resurfacing System
- A Randomised Single Centre Study to Compare the Long-term Performance of Acryloc™ and Palacos® R Bone Cements in Primary Total Hip Replacement
- A Short Metaphyseal Fitting Total Hip Arthroplasty in Young and Elderly Patients
- A Study on M2a Magnum Total Hip Arthroplasty
- Acetabular Shell Positioning Using Patient Specific Instruments
- ACI-C Versus AMIC. A Randomized Trial Comparing Two Methods for Repair of Cartilage Defects in the Knee
- Aequalis Pyrocarbon IDE; Replacing the Humeral Head in Hemi-Arthroplasty
- AEQUALIS™ FLEX REVIVE™ Study (REVIVE)
- Allofit® IT Ceramic Bearing System in Total Hip Arthroplasty
- Allofit® IT With HXPE in Total Hip Arthroplasty
- AMIStem Primary Hip System Prospective Post-marketing Multi-centre Surveillance Study
- An Electronic Data Capture Study to Assess the Long-term Performance of the DePuy PROXIMA™ Hip in Primary Total Hip Replacement
- Anatomical Shoulder Domelock System Study
- Anthology Hip Replacement System – Orthopaedic Data Evolution Panel (ODEP) Surveillance Study
- Arcos Revision Stem: Evaluation of Clinical Performance
- Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus
- Avascular Necrosis (AVN) Long-Term Follow-up
- Avenir Complete Post-Market Clinical Follow-Up Study
- Avenir Müller Hip Stem Post Market Surveillance Study
- AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone
- BC Study of G7 Cup and Compatible Femoral Stems
- Cementless Alumina-Alumina Total Hip and Hybrid
- Cementless Oxford Partial Knee Controlled Observational Study
- Ceramic On Ceramic (COC) 36mm PAS IDE Rollover Subjects; Ceramic Acetabular Bearing With Ceramic Femoral Head in Total Hip Replacement
- Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)
- Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
- Clinical and Radiological Outcomes of Medacta Shoulder System
- Clinical and Radiological Outcomes of Medacta Shoulder System (BE)
- Clinical Evaluation of the TITAN™ Total Shoulder System
- Clinical Study Comparing Two Implant Surface Finishes in Patients Undergoing Cementless Total Hip Replacement
- Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement
- Comparison of Ceramic-on-Ceramic and Ceramic-on-Highly-Cross-Linked Polyethylene Bearings
- Comparison of Hip Resurfacing to Large Femoral Head Total Hip Arthroplasty
- Comprehensive Nano – PMCF Study
- Continuum Ceramic on Ceramic Bearing Post Market Clinical Follow-Up Study
- Continuum™ Metal Bearing System in Total Hip Arthroplasty
- Core Decompression With or Without Cement Packing for ONFH
- Cormet Large Diameter Metal on Metal (LDMOM) Total Hip System (G030265)
- Cormet Post-PMA Study: New Enrollment
- CT Imaging Evaluation of Humerus Fractures
- Database Retrieval for the Comprehensive Shoulder
- Direct Anterior Versus Posterior Total Hip Arthroplasty Surgical Approaches
- Effect of Cycle Ergometer in the Rehabilitation of Elderly Patients With Total Hip Arthroplasty
- Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA
- Effects of Lacosamide on Post-operative Opioid Requirements After a Total Hip Arthroplasty:
- Efficacy of Aquamantys for Reducing Transfusions With Anterior Supine Intermuscular Approach Total Hip Arthroplasty
- Efficacy of the CLP® Hip – Retrospective
- Epidemiology and Outcomes of Upper Limb Surgery: Analysis of Routine Data
- Evaluate E1 Wear, Clinical Performance of E1 Liner in THA in Korean Patient Population
- Evaluate the Effect of Bone Marrow Derived Cd133+ Cells in Patient With Osteonecrosis of Femoral Head
- Exactech Shoulder Post Market Clinical Follow-up Study
- Exception Cementless Hip Stem
- Femoral Neck Fracture in Adult and Avascular Necrosis and Nonunion
- Fitmore Hip Stem PMCF Study: A Multi-centre, Non-comparative, Prospective Post-market Clinical Follow-up Study.
- Focused Registry on the Conservative Treatment of Osteoarthritis of the Knee
- G7 BiSpherical Acetabular Shell PMCF Study
- G7 Dual Mobility With Vivacit-E or Longevity PMCF
- G7 Freedom Constrained Vivacit-E Liners
- G7 With Vivacit-E and Longevity Post-market Follow-up Study
- Gender Solutions Natural Knee Post-Market Study
- Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer
- Human Mesenchymal Stem Cells in the Synovial Fluid of the Hip
- Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty
- Hypertension Intervention to Reduce Osteonecrosis in Children With Acute Lymphoblastic Leukemia/Lymphoma
- iAssist vs. Conventional Instrumentation in Total Knee Arthroplasty
- Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI
- Impact of a POPOP on Preoperative Health, Eligibility, and Clinical & Patient-Reported Outcomes in TJA
- In-vivo Wear Behaviour of AS Coated Versus Uncoated Columbus® Total Knee Prosthesis
- Insignia™ Hip Stem Outcomes Study
- Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study
- Ixmyelocel-T Treatment of Patients With Osteonecrosis of the Femoral Head
- Management of Mandibular ORN: PENTO as Medical Treatment
- Maxera Large Cups – Canada
- MBCP Safety and Performance in the Osteonecrosis of Femur Head
- Medial Wedge Insoles to Improve Gait in Persons After Total Hip Replacement – Randomized Control Trial
- Meditation and Opioid Consumption in Total Joint Replacement Patients Undergo Primary Total Hip and Knee Replacement
- Metal Ions in Ceramic on Metal Total Hip Arthroplasty
- Metasul Monoblock Component™ Cup in a Hip Resurfacing Application With the Durom® Hip Resurfacing Femoral Component
- Mobile – Bearing Knee Study
- Molecular Genetic Study of Avascular Necrosis of the Femoral Head
- Mononuclear Cells, Platelets and Zoledronic Acid for Preventing Collapse of the Femoral Head in Osteonecrosis
- MOTO Post-marketing Surveillance Study
- Multi Centre Study on TESS V2 Shoulder System
- Multi-centre Study to Assess the Long-term Performance of the Deltamotion Cup System in Primary Hip Replacement Surgery
- Musculoskeletal Non-tumoral Pathology Quantitative Perfusion
- Observational Study to Evaluate Long-Term Outcome in Hip Hemiarthroplasty
- Opioid-Free Shoulder Arthroplasty
- Osteonecroses in Pediatric Patients With ALL
- Osteonecrosis in Children With Acute Lymphoblastic Leukemia
- Osteonecrosis of the Hip and Bisphosphonate Treatment
- Osteoporosis and Knee Insufficiency Fracture
- Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty
- Outcomes Study of the TM Reverse Shoulder System Used in Primary or Revision Reverse Total Shoulder Arthroplasty
- Oxford Signature vs. Conventional Global Study
- Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
- Perform Humeral System Study
- Periprosthetic Bone Mineral Density After Total Hip Arthroplasty Performed Through a Minimally Invasive Anterior Approach (AMIS) With Either an AMIStem or a Quadra Femoral Component
- Persona Partial Knee Clinical Outcomes Study
- PMCF Study of the CLS Brevius Stem With Kinectiv Technology
- PMCF Study on the Safety and Performance of the Alloclassic Variall Cup Ceramic Bearing System in Total Hip Arthroplasty
- PMCF Study on the Safety and Performance of the Zimmer® Maxera™ Acetabular System in Total Hip Arthroplasty
- Post Market Clinical Follow-Up of the Zimmer Stafit Acetabular System
- Post Market Clinical Follow-Up Study for EVOLUTION® BIOFOAM® Tibia and EVOLUTION® CS/CR Porous Femur
- Post Market Clinical Follow-Up Study for EVOLUTION® NitrX™ Keeled Tibia and EVOLUTION® NitrX™ CS/CR Femur With Cruciate Sacrificing Insert
- Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis System
- Post-COVID-19 Sequelae: Osteonecrosis of Femoral Head
- Post-market Registry Study on the Physica System Total Knee Replacement
- Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
- Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects
- Project JAY THA Registration Study
- PROMIS Evaluation Study
- Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis
- Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction
- Proximal Humerus Fracture Dislocation Direction and Avascular Necrosis
- Pyrocarbon Clinical Follow-up Study
- Randomized Clinical Trial for the Treatment of Osteonecrosis of the Femoral Head
- Randomized Controlled RSA Study Comparing the Taperloc Complete Versus the Taperloc Complete Microplasty.
- Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates
- Randomized Fixed Bearing vs Mobile Bearing Cruciate Retaining TKA
- Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA
- Retrospective Study of the Linear™ Hip
- Revision Total Hip Replacement Arthroplasty and Hematologic Variables
- Rotational Thromboelstometry (ROTEM) change_colloid_total Hip Replacement Arthroplasty
- S-11 SMR TT Hybrid Glenoid and Cementless Finned Short Stem
- Safety and Effectiveness of the HIT Reverse HRS
- Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids
- SCP Hip Outcomes Study
- Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic Leukemia
- Sidus(TM) Post Market Clinical Follow-up (PMCF) Study
- Signature Acetabular Posterior/Lateral Data Collection
- Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis
- Study of Radiographic Changes and Their Clinical Implications at 2 Years of Implantation of Shortened Uncemented Femoral Stems in Total Hip Arthroplasty
- Study to Evaluate the Safety and Effectiveness of REAL INTELLIGENCE™ CORI™ in Unicondylar Knee Arthroplasty (UKA) Procedures
- Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
- Talar Avascular Necrosis: Surgical Angiogenesis vs. Core Decompression
- Taperloc Complete Microplasty vs Taperloc Complete Standard: Randomized Controlled Study on Bone Mineral Density
- TC-A Registration Study
- TESS V3 Modular Total Shoulder System PMCF
- The 3DKnee™ System: A Post-Market Study
- The British Osteonecrosis Study
- The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
- THRA_hematologic Variables
- Transplantation of Bone Marrow Stem Cells Stimulated by Proteins Scaffold to Heal Defects Articular Cartilage of the Knee
- Treatment of Medial Compartmental Osteoarthritis Grade 1-4 With TomoFix™ Small or Conservatively
- Trilogy AB Acetabular Hip System Post Approval Study
- Trinity™ BIOLOX Delta™ CoC THR Multi-center Study
- Use of Adipose Derived Regenerative Cells in Bilateral Femoral Head Osteonecrosis
- Vertebral Fracture and Osteonecrosis Associated With High-dose Glucocorticoid
- Zimmer Continuum Metal on Polyethylene (MoP) PostMarket Clinical Followup (PMCF) Study
- Zoledronic Acid Treatment of Spontaneous Osteonecrosis of the Knee
- Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease
- Cone Beam and CT Scan for the Diagnosis of Otosclerosis (TACOS)
- Cone Beam vs MDCT for Diagnosis and Pre-operative Evaluation of Otosclerosis
- Efficacy of Acetylcysteine in Patients Undergoing Surgery for Otosclerosis
- Patient Satisfaction After Surgery for Otosclerosis Under Local ou General Anesthesia
- Quantification of Prosthesis Penetration With Conebeam in Otosclerosis
- Therapeutic Efficacy of Tiludronic Acid on Inner Ear Involvement in Advanced Otosclerosis
- APL-2 and Pembrolizumab Versus APL-2, Pembrolizumab and Bevacizumab Versus Bevacizumab Alone for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer and Malignant Effusion
- Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma
- Carboplatin and Paclitaxel With or Without Bevacizumab Compared to Docetaxel, Carboplatin, and Paclitaxel in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Carcinoma (Cancer)
- Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
- EPOCH: Eribulin and Pembrolizumab in Ovarian/Uterine Carcinosarcoma
- Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
- Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib
- Study of Bevacizumab Followed by Bevacizumab Consolidation for Ovarian Cancer
- Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
- A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
- A Study Evaluating the Safety and Pharmacokinetics of QTORIN Rapamycin 3.9% Anhydrous Gel in the Treatment of Adults With Pachyonychia Congenita
- Effect of Broccoli Sprout Extract on Keratinocyte Differentiation in Normal Skin
- International Pachyonychia Congenita Research Registry
- Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
- Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita
- Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
- VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita
- Data Collection Study for the Spectrum Dynamics Multi-purpose CZT SPECT Camera
- Genetic Analysis to Predict the Development of Paget’s Disease
- Preliminary Study for Identification of Calcium-Binding Proteins in the Serum in Various Metabolic Bone Disorders
- Zoledronate In the Prevention of Paget’s Disease: Long Term Extension
- 177Lutethium – Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors
- 68Ga-OPS202 Study for Diagnostic Imaging of GEP NET
- A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus
- A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors
- A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor
- Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
- AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors
- Antitumor Efficacy of Peptide Receptor Radionuclide Therapy With 177Lutetium -Octreotate Randomized vs Sunitinib in Unresectable Progressive Well-differentiated Neuroendocrine Pancreatic Tumor: First Randomized Phase II
- Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions
- BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.
- Biomarker Study of Pancreatic Neuroendocrine Tumours
- Cabozantinib S-malate in Treating Patients With Neuroendocrine Tumors Previously Treated With Everolimus That Are Locally Advanced, Metastatic, or Cannot Be Removed by Surgery
- Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
- Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)
- Combination of Lanreotide Autogel 120mg and Temozolomide in Progressive GEP-NET
- Community-based Neuroendocrine Tumor (NET) Research Study
- Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms
- Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors
- CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms
- Database ITANET – ENETS Registry
- Diagnosis of PCL With EUS-FNA and Cross-sectional Imaging – A Report of Accuracy
- Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors
- Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Efficacy And Safety Of Sunitinib In Patients With Advanced Well-Differentiated Pancreatic Neuroendocrine Tumors
- Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib
- Endoscopic Ultrasound Guided Radio Frequency Ablation of Pancreatic Neuroendocrine Neoplasms
- EUS-FNI for MEN1-related Pancreatic Neuroendocrine Tumors
- EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors
- Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms
- Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
- Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice.
- Lutathera in People With Pancreatic Neuroendocrine Tumors That Have Spread to the Liver
- Near Infrared Technology and Laparoscopic Resection of Pancreatic Lesions: the COLPAN Project
- Neoadjuvant PRRT With Y-90-DOTATOC in pNET
- Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
- Non-functioning Pancreatic Neuroendocrine Tumors in MEN1: Somatostatin Analogs Versus NO Treatment
- Pancreatic Neuroendocrine Tumor：Factor of Surgery Influencing Survival
- Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
- Pasireotide Treatment for Neuroendocrine Tumor
- Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine Tumors
- Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma
- Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China
- Potential Molecular Predictors of Response to Novel Therapies in Metastatic Pancreatic Neuroendocrine Tumors
- Preoperative PRRT Versus Surgical Cytoreduction in Metastatic Pancreatic Neuroendocrine Tumors to the Liver
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies – Component 1
- Prospective Comprehensive Molecular Profiling In Neuroendocrine Tumors
- RAD001 and Temozolomide in Patients With Advanced Pancreatic Neuroendocrine Tumors
- Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria
- Robotic Versus Open Pancreaticoduodenectomy for Pancreatic and Periampullary Tumors
- Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions.
- Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
- Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery
- Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
- Study of CVM-1118 for Patients With Advanced Neuroendocrine Tumors
- Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors
- Study of Pancreatic Neuroendocrine Tumors and Carcinomas in Alsace Region
- Study of RYZ101 Compared With SOC in Pts With Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Study on Microflora Characteristics of Pancreatic Solid Lesions Via Endoscopic Ultrasound-guided Fine Needle Aspiration/Biopsy
- Survivin Long Peptide Vaccine in Treating Patients With Metastatic Neuroendocrine Tumors
- Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
- Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- The Safety And Efficacy Of Sunitinib In Chinese Patients With Progressive Advanced Or Metastatic Well-Differentiated Unresectable Pancreatic Neuroendocrine Tumors
- To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
- Trial Assessing Roux-en-Y Anastomosis of the Pancreatic Stump to Prevent Pancreatic Fistula Following Distal Pancreatectomy
- Variables That Are Correlated to Developing Multiple Endocrine Neoplasia (MEN) and Pancreatic Neuroendocrine Tumors (PNET)
- Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
- A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)
- Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS
- Antibiotic Treatment Trial for the PANDAS/PANS Phenotype
- Intravenous Immunoglobulin for PANDAS
- Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS
- PANS – A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort
- Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS): Clinical Characterization and Prospective Course
- Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS
- An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism
- Growth Hormone and Endothelial Function in Children
- Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
- Testosterone Gel Applied to Women With Pituitary Gland Problems
- Brain Perfusion in Pantothenate Kinase-associated Neurodegeneration (PKAN)
- CoA-Z in Pantothenate Kinase-associated Neurodegeneration (PKAN)
- Compassionate Use of Deferiprone in Patients With PKAN
- Efficacy and Safety Study of Deferiprone in Patients With Pantothenate Kinase-associated Neurodegeneration (PKAN)
- Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Patients
- Imaging Neuromelanin and Iron in Dystonia/Parkinsonism
- Long-term Deferiprone Treatment in Patients With Pantothenate Kinase-Associated Neurodegeneration
- NBIAready: Online Collection of Natural History Patient-reported Outcome Measures
- Testing of NBIA Genes: Analysis of Genetic Heterogeneity and Validation of Mitochondrial Markers for Assessing Causality of Sequence Variants.
- A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis
- Adalimumab Plus Methotrexate for the Treatment of Pediatric Uveitis
- Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
- Cyclosporine A in the Treatment of Juvenile Idiopathic Arthritis (JIA) Associated Chronic Anterior Uveitis
- Golimumab for the Treatment of Refractory Behcet’s Uveitis
- HAT in Eye Complications of Behcet’s Disease
- HUMIRA® Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
- Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis in Routine Clinical Practice
- Interferon α2a Versus Cyclosporine for Refractory Behçet`s Disease Uveitis
- Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
- Intravitreal Adalimumab Versus Subcutaneous Adalimumab in Non-infectious Uveitis
- Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients
- Prevalence of Toxoplasma Gondii and Toxocara Canis Among Patients With Uveitis
- Quality of Life and Visual Function in Uveitis Patients
- Retinal OCT and (mfERG) Related to Age, Sex, and the Use of Anti-inflammatory Medications
- Retrospective Comparison of the Efficacy of Methotrexate and Azathioprine as Background Treatment for Uveitis of Undetermined Origin: Single-centre Retrospective Study From 2005 to 2020
- Safety and Efficacy of Adalimumab Therapy for Treatment of Behcet’s Disease-related Uveitis in Sohag University Hospital
- Screening for NEI Clinical Studies
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis
- Study of Difluprednate Ophthalmic Emulsion in the Treatment of Uveitis
- Tocilizumab for the Treatment of Refractory Behcet’s Uveitis